Biotech is going to continue to be a good market.

When the IPO market tapers off, the more speculative types of issues tend to take a bigger beating than those more

We really saw the market begin to rebound in 2004 and continue through 2005, which was a very good year for us. As we look forward through 2006, we are ahead of our pace from last year.

We'd like to see Patrick continue to make the real good plays he's made and eliminate the bad ones, ... We need to be efficient.

Growth is a hard, hard thing to manage on every level. We've always risen to the occasion and we'll continue to do so.

People focus on the Nasdaq indices because in general they represent the kinds of companies that are coming out - younger companies,